The Kaplan-Meier survival curve revealed that patients with primary or metastatic melanoma who exhibited low NRP1 expression had a better overall 5-year survival than patients with high NRP1 expression (P=0.09 and 0.02, respectively; Fig. 4A, left column). The gene discussed is NRP1; the disease is metastatic melanoma.